Baricitinib reduces deaths in patients hospitalised with COVID-19 » FINCHANNEL - The FINANCIAL

The FINANCIAL -- The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. Baricitinib is an anti-inflammatory treatment normally used to treat rheumatoid arthritis. According to U…

The FINANCIAL — The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. Baricitinib is an anti-inflammatory treatment… [+6387 chars]

full article...